Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems like this might bleed off some morr until some news is released I guess? Kinda surprised but the stock has recently needed news/updates or volume dies off it seems.
Either way I'm long on phase 3 results so these ups and downs are as meaningful to me.
SBFM has 450 million shares outstanding already and a 55 million dollar market cap on some amino acid tablets and hopeful mice trials? Good luck with that, no relationship with the FDA, no antibodies created by anything yet, company doesn't have money on hand so further dilution of stock is likely. SBFM might rise if day traders and Reddit take over for a few days but this is not about to get anything approved.
I'm jealous. I bought in the 2s but not nearly enough shares. So I ended up averaging up. I should of listened to my dad who picked up 10k shares in the upper 2s but for some reason it just seemed too risky for me at the time. Oh well, have more than enough to make some money off this still
I'm with ya. I have 4k shares now and am likely gonna add 500-1000 shares this week, especially if we dip in the lower 9s with low volume. I don't plan on selling for at least another year while all our trials shake out. Hoping this is the early retirement ticket also.
I think it is tough because it'll depend on how successful the trials are, and then the estimates on sales in China and what our 10% royalty would bring us. Also u believe it would raise our price based on having a higher likelihood of US trials succeeding after successful China trials. So I'd say it should bring another 2ish billion to the market cap
Roughly $70-140 for that market cap. We have an extremely small float so share price would absolutely rocket with positive phase 1 human trials. Honestly I think we'd hit $30 a share with successful phase 1 human trials in June; even if they're outside the US. Not to mention I think we are probably 9-12 months away from our Chinese partner being done with their trials in China. I don't even want to speculate what would happen to the share price if China trials are as successful as ORMP is anticipating.
Really think you are too focused on the CDC and FDA on this one. Oramed is an Israeli company and Premas is Indian. The US market is hardly the only market in the world and like others have mentioned, shipment and storage requirements of the approved COVID vaccines are too restrictive for many countries to vaccinate the masses. Additionally, the pill would be much cheaper to produce which will be a huge competitive advantage. I agree we will barely touch the US market for initial vaccinations but we have a good chance of being involved in the second doses as well.
Overall the likelihood this becomes profitable for us is still low at this point. Human trials need to show this will produce a large antibody response which is probably 50/50. But if we clear all trials, this is easily worth 2-4 billion in market capitalization for us.
In the US I think it could be a problem because by June practically everyone who wants to get the vaccine will already have received it. The market in the US and some other countries will be lower in June. But there are planty of countries where they will fill the spots up fast.
0% chance they have trouble enrolling patients for this outside the US. Biggest markets will be outside US and I suspect they will have multiple countries running concurrent trials. US market will only really pay off if a booster is required every 12 or so months like flu and the pill world well enough to cover that.
17 million shares dumped today at 0002. Definitely not a good sign, but also who was buying such large purchases of this even at those levels? I sold half of mine at 0003 and will keep the last 2 million just for fun. Will add some at 0001 just in case we run in 4 years also lol
STOP THE PRESS!! Ice Storm Marketing has released an update!
"Very productive company retreat. Back to office today to begin instituting new direction #EESO"
This obviously means the natural light beers two guys had over the weekend was productive in trying to figure another way this company can pump up EESO to sell shares.
Agreed. I think this puts two major developments into play and we just need one to hit. I'm holding until phase 3 trials are complete with oral insulin but I would probably take a little COVID pill profit if we get there also.
I agree China will be the biggest market for oral insulin until we reach FDA approval as they will likely be approved before our trials are completed. The post I was replying to was referencing the COVID vaccine pill though. I don't know enough about where trials are going to start taking place to know where approval for that may come from first. But I do believe the first company to get approval for a COVID pill (believe we are the only major one working this now?) Will dominate the Africa and maybe India markets.
I think there are a lot of variables to determine what price increase approval would bring to the stock. FDA approval would be tbe best case scenario and in my opinion bring probably $50 or more per share increase with it. $50 is equal to about 1.5 billion in market cap which is the least that would add to our value. But this is going to be ran in many countries and I think it'll depend on which ones we ultimately get approval in. I definitely see Africa as a bigger market for the pill than the United States unless we end up having to take it as a booster yearly.
New tweet from the company on Twitter:
"Company retreat this weekend. Lots to discuss!"
My guess is the retreat is to a local McDonalds play place..
So I think the volume can be easily explained by the news released. Now why we couldn't hold our significant gains is another question? Pre-market it was apparently up as high as 18 per share with some solid trading. Feel bad for those buyers overseas but I wonder why it couldn't make a run back into the 13-14 range after markets opened.
I'm pretty sure over 1/4 of our float was traded today which is pretty crazy. New accumulation is happening which should solidify our base in the 10 range. If we break below that we could easily fall to 8-9 again but I'll just add on the dip if we do.
Is there something in the SEC findings I missed?
I'm Definitely on the opposite end of the spectrum than the rest of the board. This is obviously what is bringing volume and attention to our technology now. Even if never brought to market, this will open future partnerships and licensing deals as soon as we prove the technology is safe and effective. Plus, all we need is for this to catch the attention of some major players who come in and open million plus sized positions on the stock. Big jump in a month when we publish our results in a medical journal as they state and once the medical community reviews and accepts our early findings.
I do disagree with that as I stated in a post earlier today. This is Orameds chance to show how their technology can be successful used to deliver MANY types of medicines. If we show safe ability to deliver the COVID pill, then even if not brought to market it would solidify our ability to license the technology. Worst case scenario it proves our technology isn't safe or reliable but then we'd be screwed anyways lol. I explain more in my post earlier today I think the risk abd time spent on COVID is worth it.
I was building my position on the dip to the 7s but obviously that has been cut short. I'm up to 3650 shares and will probably stay around this level unless we see an usual dip on no news.
I think people are missing the opportunity this could present for Oramed. For one, we do not know if a yearly booster shot will be required. If it is, we would be positioned to take over that market. Additionally, there are Billions in the world who do not have access to get the COVID vaccine as the storage requirements are too difficult for developing countries. Lastly, this would prove we are able to use the technology in other medicines currently delivered by vaccine such as yearly flu shots. I think it is worth the time and resources.
Well closing at 0002 with 1.8 million shares traded is another bad sign for sure. Might be looking to just pick up another 4-5 million at 0001 and holding for the next run in 5 years..
That is true. Over the years this has had plenty of shares accumulated in the 0001-0002 range. That ride up to the 0008 and everything below it would have made them a decent amount of money.
I bought back into this knowing it would be another "pump and dump" rise up. And it might still happen. I'm here for the fake dreams they will hopefully start selling.
I don't think it is the company buying anymore. They could easily buy at 0004 if they wanted and that volume has dried up
I think the sellers are people trying to liquidate their holdings and buyers are random people hoping this jumps back to 0006.
I think your analysis is SPOT ON. Literally agree with most everything you posted. The only thing that does not make sense is why go through all the trouble of purchasing this shell stock for that quick pump and dump? Like the purchasing of EESO had to cost more than what they just made in dumping some shares at 0006-0007 for a couple days? I figured there had to be a bigger picture than that quick little run up but I might be wrong. You would think if the company was pending anything major that there would be more insiders still buying at 0004 but the fact there is barely any volume leads me to believe this might go cold for a while.
Will pick up 4 million shares at 0001 if it drops and wait for another ride years in the future lol
I was still able to find them but yea, they haven't had any updates in a while and volume dried up. Not a good sign.
https://mobile.twitter.com/Icestormmarket
I agree things are prime for EESO to take off, but company seemed to be all talk with nothing to back it up. I mean what was moving this to 0007-0008 for a while? Luckily I picked up 4 million shares at 0004 average. Hope we get something and some volume coming in. If not, I knew the gamble coming back into EESO.
Looking like another week of low volume trading and probably no updates/needs on the company...
When you say 30k at .02, do you mean 30k shares... Or dollars?? I was fortunate enough to get rid of all my shares back in 2009 for a profit even though I made way less than I had (at one point I was up $90,000 in this... I put in a couple thousand at the original 0006 before it even moved up) so I still regret not selling for more of a profit. But anyways, welcome back, hope you picked up some cheap shares to keep that average low and we get some type of news that can get you back to even or in the green on this! I'm up to 4 million shares noe and looking to add some if I can get any 0003 pickups
I have an All or Nothing purchase open for 1 million shares at 0003. I mean I don't think ANY marketing company is the next Google lol. But I'll take a shot at them pumping and dumping this up to the 004-005 range
Definitely agree. I picked up 4 million shares at 0004 and I'm starting to realize this likely has no news which could actually move this. But seems to be a lot of people holding at this level. I would think people around the company would be buying up shares at 0004-0005 still if there was actual pending news. We shall see..
Lol agreed. They are obviously on marketing 102 while we are all stuck in marketing 101 since we don't understand completely their goal. But they're the marketing company so I trust them completely!
Lol in qll seriousness I am surprised more shares haven't traded at 0003. I've had an order in for 2 weeks to fill a million shares at 0003 and it hasn't filled. People must be just waiting around.
New tweet by the company. About as empty of a tweet you can have lol. No information coming out it appears..
"The landscape of marketing has changed. We are so impressed with our ability to pivot toward the new evolution"
Definitely not a good sign to only have 50k shares traded. Where did all our volume go?!
Yea this low volume has my hopes dwindling quick that we're pending some news that can move this thing. Butttttt I'll be back on Monday hoping and praying for a bone from the company.
If your product is an environmentally friendly cleaning solution then I'm totally game! Lol I believe there are 3.6 billion shares so a hostile takeover is unlikely.
Current analysts covering:
https://money.cnn.com/quote/forecast/forecast.html?symb=ormp
Reposting this from TOUCAN so it is within 48 hours and I can sticky it.
$EESO R/M with Ice Storm Marketing LLC
thanks to judypudy & stockbane for this info
https://icestorm.com/ssd-hosting/category/marketing/
https://www.facebook.com/Icestormmarketing/
747-229-3146
https://thelondontribune.com/enzyme-environmental-solutions-inc-otceeso-acquires-ice-storm-marketing-llc/
California, USA, January 15, 2021, ZEXPRWIRE, Enzyme Environmental Solutions Inc. (OTC:EESO) is pleased to announce that it has acquired Ice Storm Marketing LLC, a California Limited Liability Company.
Ice Storm Marketing is a creative full-service interactive marketing firm based in Canoga Park, California. The company prides itself on its robust expertise in marketing, advertising, promotion, branding and public relations. It remains cognizant of the ever-changing world and, therefore, the need for adaptive advertising, virtual solutions, mobile technology and marketing strategies. Combining both written and visual skills, its staff will develop well researched, creative, appealing, objective, tailor-made and customer need-responsive advertising and marketing templates including social media posts, ads, billboards, posters, banners, digital and mainstream media advertising content.
Pursuant to the Acquisition and Merger Agreement, the current officers and directors, Reggie Sanchez and Scott Sanchez, resigned from all positions after appointing Dana Belle as both the sole officer and director.
Ms. Belle states the following, “I am excited to be a part of Enzyme Environmental. We will eventually do a name change to reflect the direction that the company is heading towards. We are also closely monitoring the SEC’s rules amending rule 15c2-11 so that we can eventually be current with OTC Markets Group Inc.”
Updates will be forthcoming
Well it isn't much, but the company replied to my tweet with below. Basically the same info we've had...
"Updates and information are on the way. Thanks for being patient"
I am pretty active on here so I'll see if I am able to be a moderator to start pinning post. You are right, no momentum is starting or stopping based on post on this board, and you should definitely not have too much in on this is any penny stock like this is another form of gambling. Best of luck to all of us.